Detalhe da pesquisa
1.
Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.
PLoS Med
; 21(5): e1004389, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38728364
2.
A 3-Year Survival Update from a Phase 2 Study of Paclitaxel Plus Cisplatin and 5-Fuorouracil Induction Chemotherapy for Locally Advanced Borderline-Resectable Esophageal Squamous Cell Carcinoma: The NEOCRTEC-1601 Clinical Trial.
Ann Surg Oncol
; 31(2): 838-846, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37919448
3.
Monitoring tumour resistance to the BRAF inhibitor combination regimen in colorectal cancer patients via circulating tumour DNA.
Drug Resist Updat
; 65: 100883, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36202008
4.
Genomic temporal heterogeneity of circulating tumour DNA in unresectable metastatic colorectal cancer under first-line treatment.
Gut
; 71(7): 1340-1349, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34489309
5.
Circulating Lipid- and Inflammation-Based Risk (CLIR) Score: A Promising New Model for Predicting Outcomes in Complete Colorectal Liver Metastases Resection.
Ann Surg Oncol
; 2022 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35254582
6.
Heterogeneity and evolution of tumour immune microenvironment in metastatic gastroesophageal adenocarcinoma.
Gastric Cancer
; 25(6): 1017-1030, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35904677
7.
Recombinant human endostatin plus paclitaxel/nedaplatin for recurrent or metastatic advanced esophageal squamous cell carcinoma: a prospective, single-arm, open-label, phase II study.
Invest New Drugs
; 39(2): 516-523, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33070249
8.
Efficacy and safety of modified FOLFIRINOX as salvage therapy for patients with refractory advanced biliary tract cancer: a retrospective study.
Invest New Drugs
; 39(3): 836-845, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33411209
9.
Circular RNA: metabolism, functions and interactions with proteins.
Mol Cancer
; 19(1): 172, 2020 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33317550
10.
Histopathological growth patterns correlate with the immunoscore in colorectal cancer liver metastasis patients after hepatectomy.
Cancer Immunol Immunother
; 69(12): 2623-2634, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32601799
11.
Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer.
Gut
; 68(7): 1152-1161, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30269082
12.
LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer.
Mol Cancer
; 18(1): 174, 2019 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31791342
13.
Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer.
BMC Cancer
; 19(1): 460, 2019 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31096937
14.
The Immunoscore system predicts prognosis after liver metastasectomy in colorectal cancer liver metastases.
Cancer Immunol Immunother
; 67(3): 435-444, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29204700
15.
Suppression of ABCG2 mediated MDR in vitro and in vivo by a novel inhibitor of ABCG2 drug transport.
Pharmacol Res
; 121: 184-193, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28455266
16.
Efficacy and safety of cisplatin-based versus nedaplatin-based regimens for the treatment of metastatic/recurrent and advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Dis Esophagus
; 30(2): 1-8, 2017 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27868295
17.
The predictive value of alkaline phosphatase and lactate dehydrogenase for overall survival in patients with esophageal squamous cell carcinoma.
Tumour Biol
; 37(2): 1879-87, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26323257
18.
Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
Hepatology
; 60(2): 598-609, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24616020
19.
A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.
BMC Cancer
; 15: 350, 2015 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25934640
20.
Right-sided colon cancer and left-sided colorectal cancers respond differently to cetuximab.
Chin J Cancer
; 34(9): 384-93, 2015 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26111811